Healthcare Realty Trust (NYSE:HR) Announces Earnings Results

Healthcare Realty Trust (NYSE:HR) posted its quarterly earnings results on Thursday. The real estate investment trust reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01, Zacks reports. The business had revenue of $278.58 million during the quarter, compared to analysts’ expectations of $271.60 million. Healthcare Realty Trust had a negative net margin of 17.34% and a negative return on equity of 4.29%. The business’s quarterly revenue was down 5.3% on a year-over-year basis. During the same period last year, the company posted $0.41 earnings per share. Healthcare Realty Trust updated its FY 2026 guidance to 1.620-1.660 EPS.

Healthcare Realty Trust Trading Down 1.5%

Shares of NYSE HR traded down $0.33 during midday trading on Thursday, hitting $21.48. 4,056,788 shares of the company’s stock were exchanged, compared to its average volume of 3,536,718. Healthcare Realty Trust has a 12-month low of $15.28 and a 12-month high of $22.04. The company has a market cap of $7.44 billion, a price-to-earnings ratio of -37.04 and a beta of 0.98. The business’s fifty day moving average price is $20.54 and its two-hundred day moving average price is $18.93.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on HR. Scotiabank boosted their price target on shares of Healthcare Realty Trust from $20.00 to $22.00 and gave the company an “outperform” rating in a research note on Friday, May 8th. Cantor Fitzgerald boosted their target price on shares of Healthcare Realty Trust from $21.00 to $22.00 and gave the company an “overweight” rating in a research note on Monday, May 4th. BTIG Research reissued a “buy” rating and issued a $22.00 target price on shares of Healthcare Realty Trust in a research report on Friday, June 12th. Raymond James Financial began coverage on shares of Healthcare Realty Trust in a report on Tuesday, June 16th. They set an “outperform” rating and a $24.00 price objective on the stock. Finally, UBS Group lifted their target price on shares of Healthcare Realty Trust from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 8th. Four equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $21.67.

Insider Activity at Healthcare Realty Trust

In other news, CAO Amanda L. Callaway sold 25,767 shares of Healthcare Realty Trust stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $20.37, for a total transaction of $524,873.79. Following the completion of the sale, the chief accounting officer directly owned 109,954 shares of the company’s stock, valued at approximately $2,239,762.98. The trade was a 18.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.56% of the stock is owned by insiders.

Hedge Funds Weigh In On Healthcare Realty Trust

A number of large investors have recently bought and sold shares of HR. Invesco Ltd. lifted its position in Healthcare Realty Trust by 233.8% in the third quarter. Invesco Ltd. now owns 7,700,760 shares of the real estate investment trust’s stock valued at $138,845,000 after purchasing an additional 5,393,651 shares during the last quarter. Rush Island Management LP grew its holdings in shares of Healthcare Realty Trust by 13.8% in the second quarter. Rush Island Management LP now owns 14,260,152 shares of the real estate investment trust’s stock worth $226,166,000 after purchasing an additional 1,728,491 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Healthcare Realty Trust by 418.3% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,947,274 shares of the real estate investment trust’s stock worth $35,109,000 after purchasing an additional 1,571,583 shares during the last quarter. UBS Group AG increased its stake in shares of Healthcare Realty Trust by 124.0% in the third quarter. UBS Group AG now owns 2,282,951 shares of the real estate investment trust’s stock worth $41,162,000 after buying an additional 1,263,863 shares during the period. Finally, Gotham Asset Management LLC increased its stake in shares of Healthcare Realty Trust by 122.0% in the third quarter. Gotham Asset Management LLC now owns 1,269,969 shares of the real estate investment trust’s stock worth $22,898,000 after buying an additional 697,970 shares during the period.

About Healthcare Realty Trust

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.